Related Experiment Videos
Two-coil versus single-coil transvenous cardioverter defibrillator systems: comparative data
A S Manolis1, J Chiladakis, T N Maounis
1Patras University, Patras, Greece.
Pacing and Clinical Electrophysiology : PACE
|January 5, 2001
Summary
New implantable cardioverter-defibrillator (ICD) systems with single-coil and dual-coil leads show high implantation success and low complications. Dual-coil leads may be preferable to avoid additional lead implantation.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- New-generation transvenous implantable cardioverter-defibrillator (ICD) systems are crucial for managing life-threatening arrhythmias.
- Comparing single-coil versus dual-coil lead systems is essential for optimizing device performance and patient outcomes.
Purpose of the Study:
- To compare the efficacy and safety of new-generation transvenous ICD systems with single-coil versus dual-coil lead configurations.
- To evaluate implantation success rates, defibrillation thresholds, and lead-related complications in both systems.
Main Methods:
- A comparative study of 94 patients undergoing transvenous ICD implantation.
- Patients were divided into two groups: dual-coil lead system (n=62) and single-coil lead system (n=32).
- Intraoperative testing included defibrillation threshold (DFT), pacing threshold, R wave amplitude, and lead impedance.
Main Results:
- Both single-coil and dual-coil ICD systems demonstrated high implantation success rates and low lead-related complications.
- Comparable defibrillation threshold (DFT) and pacing thresholds were observed between the two groups.
- Lower R wave amplitude and lead impedance were noted in the dual-coil group, potentially due to active fixation characteristics.
Conclusions:
- Both single-coil and dual-coil transvenous ICD systems are effective and safe, with high implantation success and low complication rates.
- While both systems perform well, the dual-coil lead system may offer advantages in preventing the occasional need for additional endocardial leads.